Franklin Resources’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$80.5M Buy
611,264
+78,505
+15% +$10.4M 0.02% 491
2025
Q4
$75.6M Sell
532,759
-102,206
-16% -$14.8M 0.02% 509
2025
Q3
$89.1M Sell
634,965
-68,556
-10% -$9.29M 0.02% 462
2025
Q2
$88.4M Buy
703,521
+124,092
+21% +$14.2M 0.02% 451
2025
Q1
$64.1M Sell
579,429
-29,506
-5% -$3.74M 0.02% 532
2024
Q4
$83.1M Sell
608,935
-55,401
-8% -$6.85M 0.02% 461
2024
Q3
$77.4M Sell
664,336
-144,114
-18% -$19.8M 0.02% 468
2024
Q2
$111M Buy
808,450
+14,625
+2% +$2.01M 0.03% 387
2024
Q1
$109M Buy
793,825
+21,515
+3% +$2.94M 0.03% 394
2023
Q4
$102M Buy
772,310
+6,124
+0.8% +$705K 0.05% 349
2023
Q3
$86.2M Buy
766,186
+37,936
+5% +$3.99M 0.04% 378
2023
Q2
$68.7M Buy
728,250
+17,806
+3% +$1.74M 0.03% 446
2023
Q1
$71.9M Buy
710,444
+16,672
+2% +$1.73M 0.04% 432
2022
Q4
$82.9M Sell
693,772
-358,463
-34% -$42M 0.04% 406
2022
Q3
$112M Sell
1,052,235
-128,820
-11% -$13.1M 0.06% 353
2022
Q2
$115M Buy
1,181,055
+65,313
+6% +$6.03M 0.06% 353
2022
Q1
$105M Buy
1,115,742
+151,921
+16% +$12.9M 0.04% 423
2021
Q4
$82.1M Sell
963,821
-203
-0% -$18.7K 0.03% 508
2021
Q3
$92.5M Buy
964,024
+1,490
+0.2% +$141K 0.03% 489
2021
Q2
$93.7M Buy
962,534
+57,680
+6% +$5.53M 0.04% 482
2021
Q1
$88M Buy
904,854
+9,984
+1% +$1.05M 0.04% 468
2020
Q4
$85.8M Sell
894,870
-635,290
-42% -$61.4M 0.04% 463
2020
Q3
$147M Buy
1,530,160
+77,878
+5% +$9.01M 0.07% 292
2020
Q2
$189M Sell
1,452,282
-225,399
-13% -$24.9M 0.1% 243
2020
Q1
$145M Sell
1,677,681
-305,818
-15% -$29.9M 0.1% 234
2019
Q4
$213M Buy
1,983,499
+122,980
+7% +$12.9M 0.11% 226
2019
Q3
$168M Buy
1,860,519
+208,688
+13% +$19.5M 0.09% 264
2019
Q2
$139M Sell
1,651,831
-387,307
-19% -$31.8M 0.07% 288
2019
Q1
$180M Buy
2,039,138
+14,200
+0.7% +$1.19M 0.1% 253
2018
Q4
$145M Buy
2,024,938
+184,415
+10% +$17.7M 0.09% 259
2018
Q3
$226M Buy
1,840,523
+15,137
+0.8% +$1.72M 0.11% 218
2018
Q2
$179M Sell
1,825,386
-531,200
-23% -$47.5M 0.09% 243
2018
Q1
$195M Sell
2,356,586
-714,800
-23% -$60.4M 0.1% 226
2017
Q4
$238M Sell
3,071,386
-194,229
-6% -$13.2M 0.11% 209
2017
Q3
$200M Sell
3,265,615
-113,000
-3% -$5.96M 0.1% 230
2017
Q2
$155M Buy
3,378,615
+579,900
+21% +$28.1M 0.08% 262
2017
Q1
$121M Buy
2,798,715
+389,000
+16% +$16.7M 0.06% 316
2016
Q4
$93.3M Buy
2,409,715
+397,429
+20% +$18M 0.05% 363
2016
Q3
$102M Buy
2,012,286
+470,840
+31% +$23.4M 0.05% 345
2016
Q2
$70.1M Buy
1,541,446
+380,841
+33% +$17.5M 0.04% 441
2016
Q1
$45.9M Sell
1,160,605
-39,695
-3% -$1.58M 0.02% 554
2015
Q4
$67.9M Sell
1,200,300
-40,400
-3% -$2.05M 0.03% 462
2015
Q3
$49.4M Sell
1,240,700
-113,700
-8% -$5.5M 0.02% 563
2015
Q2
$64.7M Hold
1,354,400
0.03% 520
2015
Q1
$53.8M Sell
1,354,400
-571,600
-30% -$20.4M 0.02% 574
2014
Q4
$43M Buy
1,926,000
+87,600
+5% +$1.66M 0.02% 647
2014
Q3
$28.8M Sell
1,838,400
-365,800
-17% -$5.47M 0.01% 766
2014
Q2
$32.7M Hold
2,204,200
0.01% 737
2014
Q1
$35.5M Buy
2,204,200
+105,600
+5% +$1.81M 0.02% 706
2013
Q4
$19.6M Buy
2,098,600
+495,800
+31% +$4.84M 0.01% 814
2013
Q3
$18.1M Buy
1,602,800
+154,400
+11% +$2.12M 0.01% 825
2013
Q2
$19.4M Buy
+1,448,400
New +$17.8M 0.01% 764

Other funds holding NBIX